Drug intelligence / Profile preview

fuzheng qingyu

Development stage: Preclinical
Lead developer: Yueyang Hospital of Integrated Traditional Chinese and Western Medicine
Administration: Oral

Overview

Fuzheng Qingyu is a Traditional Chinese Medicine (TCM) formula investigated for the treatment of dysmenorrhea associated with adenomyosis. Its therapeutic approach is described within TCM principles as strengthening the body's resistance and removing blood stasis.

Other names: Fuzheng Qingyu formula

Beyond the preview

Go deeper on fuzheng qingyu.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on fuzheng qingyu.

Explore the full profile